Showing 1 - 17 results of 17 for search 'L. Paris', query time: 0.05s
Refine Results
-
1
INTEGRATED DIGITAL SURVEY OF THE "FONTANA RUSTICA" IN THE GARDENS OF THE QUIRINALE. by L. Paris, W. Troiano
Published 2013-07-01
Article -
2
-
3
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review by Juan L. Paris, María Vallet-Regí
Published 2020-06-01
Article -
4
-
5
-
6
-
7
-
8
Endostatin Genetically Engineered Placental Mesenchymal Stromal Cells Carrying Doxorubicin-Loaded Mesoporous Silica Nanoparticles for Combined Chemo- and Antiangiogenic Therapy by Paz de la Torre, Juan L. Paris, Miguel Fernández-de la Torre, María Vallet-Regí, Ana I. Flores
Published 2021-02-01
Article -
9
-
10
Multifuntional Gold Nanoparticles for the SERS Detection of Pathogens Combined with a LAMP–in–Microdroplets Approach by Alexandra Teixeira, Juan L. Paris, Foteini Roumani, Lorena Diéguez, Marta Prado, Begoña Espiña, Sara Abalde-Cela, Alejandro Garrido-Maestu, Laura Rodriguez-Lorenzo
Published 2020-04-01
Article -
11
-
12
Genomic Profiling of Hormone-Naïve Lymph Node Metastases in Patients with Prostate Cancer by Pamela L. Paris, Matthias D. Hofer, Giancarlo Albo, Rainer Kuefer, Juergen E. Gschwend, Richard E. Hautmann, Jane Fridyland, Jeffrey Simko, Peter R. Carroll, Mark A. Rubin, Colin Collins
Published 2006-12-01
Article -
13
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer by Clinton L. Cario, Emmalyn Chen, Lancelote Leong, Nima C. Emami, Karen Lopez, Imelda Tenggara, Jeffry P. Simko, Terence W. Friedlander, Patricia S. Li, Pamela L. Paris, Peter R. Carroll, John S. Witte
Published 2020-08-01
Article -
14
Evaluation of an Oral Supplemental Cannabidiol Product for Acceptability and Performance in Mature Horses by Julia M. Leise, Jessica L. Leatherwood, Brittany L. Paris, Kelly W. Walter, James M. George, Rafael E. Martinez, Kati P. Glass, Chih-Ping Lo, Travis P. Mays, Tryon A. Wickersham
Published 2023-01-01
Article -
15
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival by Yalei Chen, Sudha M. Sadasivan, Ruicong She, Indrani Datta, Kanika Taneja, Dhananjay Chitale, Nilesh Gupta, Melissa B. Davis, Lisa A. Newman, Craig G. Rogers, Pamela L. Paris, Jia Li, Benjamin A. Rybicki, Albert M. Levin
Published 2020-08-01
Article -
16
P39 DEDALO: PHASE II STUDY OF DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION by V. Montefusco, A.M. Cafro, G. Margiotta Casaluci, F. Patriarca, R. Mina, M. D’Agostino, A. Capra, C. Priola, B. Dalla Palma, R. Rizzi, A. Genua, M.T. Petrucci, L. Paris, A. Belotti, M. Cavo, C. Conticello, C. Carlo-Stella, M Boccadoro
Published 2023-05-01
Article -
17
Cell-free DNA concentration and fragment size as a biomarker for prostate cancer by Emmalyn Chen, Clinton L. Cario, Lancelote Leong, Karen Lopez, César P. Márquez, Carissa Chu, Patricia S. Li, Erica Oropeza, Imelda Tenggara, Janet Cowan, Jeffry P. Simko, June M. Chan, Terence Friedlander, Alexander W. Wyatt, Rahul Aggarwal, Pamela L. Paris, Peter R. Carroll, Felix Feng, John S. Witte
Published 2021-03-01
Article